One in three HIV patients say life 'better' since diagnosis

April 30, 2003

VANCOUVER -- Nearly a third of patients with the AIDS virus say life is generally better since they received their diagnosis, according to study findings presented May 1 at the annual meeting of the Society of General Internal Medicine in Vancouver, B.C. The study was based on interviews with 449 HIV patients in 2002 and 2003.

According to lead researcher Joel Tsevat, M.D., M.P.H., a physician and researcher with the Veterans Healthcare System of Ohio and the University of Cincinnati Medical Center, the study is one of few to show that, surprisingly, many seriously ill patients are happier with life since their diagnosis. He cited anecdotal reports of this phenomenon from nurses, psychologists and other healthcare providers, but said there is scant evidence of it in the medical literature.

In the study, funded by the Department of Veterans Affairs and the National Center for Complementary and Alternative Medicine, patients compared their life before and after their diagnosis. About 32 percent said life was "better" since they learned they were HIV positive; 29 percent said life was "worse" 26 percent said life was "about the same" and the others said they "didn't know." The patients were recruited from two VA medical centers and two university medical centers.

The researchers found that patients who said life had improved reported fewer worries about finances or disclosure of their illness than the other patients. They expressed more optimism and greater life satisfaction, and were more likely to participate in non-organized religious activities, such as prayer, meditation or Bible study. Those who said life was better were almost equally represented among the three classes of HIV patients in the study: patients without symptoms, those with symptoms but without AIDS, and those with full-blown AIDS. About 61 percent of patients in the study had AIDS, as defined by the Centers for Disease Control and Prevention.

Tsevat said the findings jibed with those from a smaller study of HIV patients he conducted in the mid-1990s. In that study, he said, many HIV-positive patients reported "they had learned to appreciate life more than they used to. They no longer took things for granted. Things like a nice day, a change in the seasons, family --they just appreciated what they had a lot more."

Tsevat's team will follow patients in the study for an additional 15 months to learn more about the factors associated with increased post-diagnosis satisfaction. A long-range goal of the research is to design and test interventions to help patients better cope with their illness.

"If we say a third of patients think life is better, what can we do for the other two-thirds, who haven't gotten to that point? Interventions might include, for example, providing more financial support or counseling for HIV patients, or referring them to chaplains for spiritual or religious guidance," said Tsevat.
Tsevat's collaborators on the study were Dr. Susan N. Sherman, Veterans Healthcare System of Ohio and University of Cincinnati Medical Center; Dr. Judith Feinberg, UCMC; Drs. Joseph M. Mrus, Anthony C. Leonard and Karen L. Mandell, VHSO and UCMC; Dr. William C. Holmes, University of Pennsylvania; Drs. Amy C. Justice and Shawn L. Fultz, VA Pittsburgh Healthcare System; and Dr. Christina M. Puchalski, George Washington University Medical Center.

SPECIAL NOTE TO REPORTERS: If you are not attending the Society of General Internal Medicine (SGIM) conference, but would like to pursue a story, Joel Tsevat, M.D., M.P.H., is available for press interviews, April 30, 2003 thru May 3, 2003. Please contact the SGIM Communications Director, Lorraine Tracton, at 604-647-7401. Dr. Tsevat can also be reached at the Pan Pacific Hotel, 604-662-8111 or After May 3, please call Suzanne Tate, Veterans Healthcare System of Ohio, at 513-475-6516 or For additional assistance, please contact Jim Blue at 212-807-3429.

Veterans Affairs Research Communications

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to